Antibiotics in Pneumonia: Modern Treatment Approaches

Pneumonia remains one of the major causes of morbidity and mortality worldwide. In most cases, it is caused by bacterial infections, making antibacterial therapy the cornerstone of successful treatment. However, choosing the right antibiotic is a complex task that requires considering multiple factors: from the type of pathogen and its susceptibility to the patient's condition and the presence of comorbid diseases. The continuous development of pulmonology and the emergence of new challenges, such as the rise of antibiotic resistance, dictate the need for constant updating of treatment approaches [1, 2].

Empirical Antibacterial Therapy: The First Step to Success

Often, upon admission of a patient with pneumonia, the exact pathogen of the infection is not yet known. In such cases, physicians resort to so-called empirical antibacterial therapy. This means that antibiotics are prescribed based on the most likely pathogens characteristic of the given type of pneumonia (e.g., community-acquired or hospital-acquired), as well as taking into account the epidemiological situation and local resistance data [5, 6, 8].

Key principles of empirical therapy:

• Timeliness: For patients with severe sepsis or septic shock, which can develop against the background of pneumonia, it is critical to initiate antibiotic therapy within the first hour after the identification of organ dysfunction. This significantly improves survival and reduces complications [7, 8].
• Broad spectrum of activity: Initially, broad-spectrum antibiotics capable of covering the most likely pathogens are often used [5, 7].
• Consideration of local epidemiology: The choice of drugs should be based on data on bacteriological susceptibility characteristic of a specific medical institution or region [5, 6, 8].
• Individual approach: It is necessary to consider patient allergies (e.g., to penicillin, which may limit the use of cephalosporins and carbapenems) and other factors [5].

Main Classes of Antibiotics in Pneumonia

Depending on the clinical situation and the suspected pathogen, various groups of antibiotics can be used for pneumonia:

• Beta-lactams: These include penicillins (e.g., ampicillin), cephalosporins, and carbapenems. They are widely used both in monotherapy and in combination [2, 4, 5].
• Aminoglycosides: Drugs such as gentamicin are potent antibiotics effective against many gram-negative bacteria. They are often used in combination with beta-lactam antibiotics, especially in severe infections. It is important to monitor their serum concentration to ensure efficacy and minimize side effects [2, 4].
• Macrolides and fluoroquinolones: Frequently used in community-acquired pneumonia, especially when atypical pathogens are suspected.
• Antibiotics to combat resistant strains: When an infection caused by methicillin-resistant Staphylococcus aureus (MRSA) is suspected or confirmed, specific drugs may be required. These include vancomycin and daptomycin, approved by the FDA for monotherapy. In cases of persistent MRSA bacteraemia where initial therapy is ineffective, combination strategies involving vancomycin with beta-lactams, as well as ceftaroline, linezolid, telavancin, or trimethoprim/sulfamethoxazole, may be used [3].

De-escalation and Monitoring of Therapy

After receiving the results of microbiological studies (sputum and blood cultures) and determining the susceptibility of the pathogen to antibiotics, therapy de-escalation is performed [7]. This means transitioning from a broad-spectrum to a more targeted antibiotic that will be maximally effective against the identified pathogen while having fewer side effects. This approach helps reduce the risk of developing antibiotic resistance and decreases toxicity for the patient.

Understanding the pharmacokinetic properties of antibacterial drugs is of great importance, especially in patients with sepsis, where physiological changes can significantly affect drug distribution and elimination [5, 7]. Regular monitoring of the patient's condition and, if necessary, antibiotic concentrations in the blood (e.g., for aminoglycosides) allows for dose optimization and treatment efficacy improvement while minimizing risks [4].

Challenges of Antibiotic Resistance

The rise of antibiotic resistance is one of the most serious threats to modern healthcare. Microorganisms constantly develop resistance mechanisms to existing drugs, making the treatment of many infections increasingly complex [2, 7]. This is particularly relevant for hospital-acquired infections, where multidrug-resistant strains are frequently encountered [3, 5].

To combat this problem, the following are necessary:

• Rational use of antibiotics, strictly according to indications.
• Development of new antibacterial drugs and treatment strategies.
• Continuous monitoring of resistance at local and global levels.
• Compliance with hygiene measures to prevent the spread of infections.

The correct choice and timely prescription of antibiotics remain key factors in the successful treatment of pneumonia, especially in the context of the growing threat of antibiotic resistance.

Sources

1. Pulmonology: What You May Have Missed in 2024. https://pubmed.ncbi.nlm.nih.gov/40163874/
2. Reviewing the WHO guidelines for antibiotic use for sepsis in neonates and children. https://pubmed.ncbi.nlm.nih.gov/29790842/
3. When sepsis persists: a review of MRSA bacteraemia salvage therapy. https://pubmed.ncbi.nlm.nih.gov/26565015/
4. Aminoglycoside antibiotics in infectious diseases. An overview. https://pubmed.ncbi.nlm.nih.gov/3524216/
5. Empiric Antibiotic Therapy of Nosocomial Bacterial Infections. https://pubmed.ncbi.nlm.nih.gov/24413366/
6. Drugs for the Prevention and Treatment of Sepsis in the Newborn. https://pubmed.ncbi.nlm.nih.gov/31010563/
7. Bench-to-bedside review: Appropriate antibiotic therapy in severe sepsis and septic shock--does the dose matter? https://pubmed.ncbi.nlm.nih.gov/19519961/
8. Antibiotic management of sepsis: current concepts. https://pubmed.ncbi.nlm.nih.gov/18937614/

Disclaimer: The information presented in this article is for informational purposes only and cannot replace an in-person consultation with a qualified medical specialist. Self-medication can be hazardous to your health.